Guardant Health Stock Price Prediction
| GH Stock | USD 16.39 0.23 1.42% |
Oversold Vs Overbought
43
Oversold | Overbought |
Guardant Health stock price prediction is an act of determining the future value of Guardant Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Guardant Health's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Guardant Health and does not consider all of the tangible or intangible factors available from Guardant Health's fundamental data. We analyze noise-free headlines and recent hype associated with Guardant Health, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Guardant Health's stock price prediction:EPS Estimate Next Quarter (0.87) | EPS Estimate Current Year (3.16) | EPS Estimate Next Year (2.86) | Wall Street Target Price 39.06 | Quarterly Revenue Growth 0.222 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Guardant Health based on different types of headlines from major news networks to social media. The Guardant stock price prediction module provides an analysis of price elasticity to changes in media outlook on Guardant Health over a specific investment horizon. Using Guardant Health hype-based prediction, you can estimate the value of Guardant Health from the perspective of Guardant Health response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Guardant Health using Guardant Health's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Guardant using crowd psychology based on the activity and movement of Guardant Health's stock price.
Guardant Health Short Interest
A significant increase or decrease in Guardant Health's short interest from the previous month could be a good indicator of investor sentiment towards Guardant. Short interest can provide insight into the potential direction of Guardant Health stock and how bullish or bearish investors feel about the market overall. An investor who is long Guardant Health may also wish to track short interest. As short interest increases, investors should be becoming more worried about Guardant Health and may potentially protect profits, hedge Guardant Health with its derivative instruments, or be ready for some potential downside.
200 Day MA 27.1747 | Short Percent 0.0654 | Short Ratio 4.1 | Shares Short Prior Month 7.8 M | 50 Day MA 19.586 |
Guardant Health Hype to Price Pattern
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Guardant Health's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Guardant Health.
Guardant Health Implied Volatility | 273.91 |
Guardant Health's implied volatility exposes the market's sentiment of Guardant Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Guardant Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Guardant Health stock will not fluctuate a lot when Guardant Health's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Guardant Health. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Guardant Health to buy its stock at a price that has no basis in reality. In that case, they are not buying Guardant because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Guardant Health after-hype prediction price | USD 16.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Guardant |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardant Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardant Health After-Hype Price Prediction Density Analysis
As far as predicting the price of Guardant Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Guardant Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Guardant Health, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Guardant Health Estimiated After-Hype Price Volatility
In the context of predicting Guardant Health's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Guardant Health's historical news coverage. Guardant Health's after-hype downside and upside margins for the prediction period are 12.34 and 20.44, respectively. We have considered Guardant Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Guardant Health is somewhat reliable at this time. Analysis and calculation of next after-hype price of Guardant Health is based on 3 months time horizon.
Guardant Health Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Guardant Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardant Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Guardant Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.05 | 0.16 | 0.69 | 9 Events / Month | 4 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.39 | 16.39 | 0.00 |
|
Guardant Health Hype Timeline
As of April 18, 2024 Guardant Health is listed for 16.39. The entity has historical hype elasticity of -0.16, and average elasticity to hype of competition of 0.69. Guardant is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.47%. %. The volatility of related hype on Guardant Health is about 275.2%, with the expected price after the next announcement by competition of 17.08. About 94.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.28. Guardant Health had not issued any dividends in recent years. Allowing for the 90-day total investment horizon the next forecasted press release will be in about 9 days. Check out Guardant Health Basic Forecasting Models to cross-verify your projections.Guardant Health Related Hype Analysis
Having access to credible news sources related to Guardant Health's direct competition is more important than ever and may enhance your ability to predict Guardant Health's future price movements. Getting to know how Guardant Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Guardant Health may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ILMN | Illumina | 2.26 | 9 per month | 0.00 | (0.12) | 3.65 | (3.83) | 9.89 | |
| TWST | Twist Bioscience Corp | (0.05) | 11 per month | 0.00 | (0.09) | 6.34 | (5.54) | 18.88 | |
| MYGN | Myriad Genetics | (0.40) | 10 per month | 0.00 | (0.04) | 4.77 | (4.98) | 17.90 | |
| A | Agilent Technologies | 0.66 | 10 per month | 1.41 | 0 | 2.26 | (2.44) | 6.31 | |
| TMO | Thermo Fisher Scientific | 5.42 | 11 per month | 1.26 | (0.03) | 1.80 | (1.63) | 6.87 | |
| DHR | Danaher | 0.94 | 13 per month | 1.05 | 0.04 | 2.27 | (1.66) | 7.45 |
Guardant Health Additional Predictive Modules
Most predictive techniques to examine Guardant price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Guardant using various technical indicators. When you analyze Guardant charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Guardant Health Predictive Indicators
The successful prediction of Guardant Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Guardant Health, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Guardant Health based on analysis of Guardant Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Guardant Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Guardant Health's related companies. | 2021 | 2023 | 2024 (projected) | Dividend Yield | 0.001763 | 0.002027 | 0.001866 | Price To Sales Ratio | 27.12 | 5.37 | 5.1 |
Story Coverage note for Guardant Health
The number of cover stories for Guardant Health depends on current market conditions and Guardant Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Guardant Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Guardant Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Guardant Health Short Properties
Guardant Health's future price predictability will typically decrease when Guardant Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Guardant Health often depends not only on the future outlook of the potential Guardant Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardant Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 112 M | |
| Cash And Short Term Investments | 1.2 B |
Check out Guardant Health Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.